| Pharmaceutical active ingredients: |
| Ambroxol HydrochlorideOxeladin Citrate |
| Available forms, composition and doses of TheraFlu-Tenalif: |
| Tablets; Oral; Ambroxol Hydrochloride 25 mg; Oxeladin Citrate 20 mg |
| TheraFlu-Tenalif medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R05CB06 - AmbroxolR05DB09 - Oxeladin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ambiac | Ambroxol Hydrochloride; N-Acetylcysteine | Esma Formulations |
| Koxcure | Ambroxol Hydrochloride; N-Acetylcysteine | Akums Drugs & Pharmaceuticals |
| Ventirex-A | Ambroxol Hydrochloride; N-Acetylcysteine | Unimarck Pharma India |
| Connexus | Ambroxol Hydrochloride; Oxeladin Citrate | Rayere Farmaceuticos |
| Tenalif | Ambroxol Hydrochloride; Oxeladin Citrate | Novartis; Columbia Laboratorios |
| Vaxal | Ambroxol Hydrochloride; Oxeladin Citrate | Andromaco Laboratorios |
| Avirox-AM | Ambroxol Hydrochloride; Roxithromycin | Avalanche Pharmaceuticals |
| Medirox-A | Ambroxol Hydrochloride; Roxithromycin | Medopharm |
| Ralrox-A | Ambroxol Hydrochloride; Roxithromycin | Shreya Life Sciences |
| Roxcer | Ambroxol Hydrochloride; Roxithromycin | USV, India |